LFMD LifeMD Inc
Price (delayed)
$5.61
Market cap
$250.11M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.53
Enterprise value
$240.21M
LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordable
Highlights
The gross profit has grown by 41% YoY and by 9% from the previous quarter
The revenue has grown by 39% YoY and by 10% from the previous quarter
The quick ratio has contracted by 35% YoY and by 2.7% from the previous quarter
The debt is up by 33% year-on-year
Key stats
What are the main financial stats of LFMD
Market
Valuations
Earnings
Shares outstanding
44.58M
Market cap
$250.11M
Enterprise value
$240.21M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.13
Revenue
$212.45M
Gross profit
$188.39M
Operating income
-$16.14M
Net income
-$18.88M
EBIT
-$16.3M
EBITDA
-$6.03M
Free cash flow
$5.98M
Per share
Balance sheet
Liquidity
EPS
-$0.53
EPS diluted
-$0.53
Free cash flow per share
$0.15
Book value per share
-$0.13
Revenue per share
$5.16
TBVPS
$1.37
Total assets
$72.46M
Total liabilities
$76.51M
Debt
$25.1M
Equity
-$5.49M
Working capital
-$11.52M
Debt to equity
-4.58
Current ratio
0.81
Quick ratio
0.72
Net debt/EBITDA
1.64
Margins
Efficiency
Dividend
EBITDA margin
-2.8%
Gross margin
88.7%
Net margin
-8.9%
Operating margin
-7.6%
Return on assets
-32.5%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-133.5%
Return on sales
-7.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LFMD stock price
How has the LifeMD stock price performed over time
Intraday
3.31%
1 week
-6.11%
1 month
6.65%
1 year
-43.33%
YTD
13.33%
QTD
3.13%
Financial performance
How have LifeMD's revenue and profit performed over time
Revenue
$212.45M
Gross profit
$188.39M
Operating income
-$16.14M
Net income
-$18.88M
Gross margin
88.7%
Net margin
-8.9%
The gross profit has grown by 41% YoY and by 9% from the previous quarter
The revenue has grown by 39% YoY and by 10% from the previous quarter
The net margin is up by 34% year-on-year and by 24% since the previous quarter
LFMD's operating margin is up by 24% since the previous quarter and by 20% year-on-year
Growth
What is LifeMD's growth rate over time
Valuation
What is LifeMD stock price valuation
P/E
N/A
P/B
N/A
P/S
1.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.13
The EPS has grown by 24% YoY and by 17% from the previous quarter
LifeMD's equity has increased by 29% QoQ
The P/S is 45% below the 5-year quarterly average of 1.9 and 30% below the last 4 quarters average of 1.5
The revenue has grown by 39% YoY and by 10% from the previous quarter
Efficiency
How efficient is LifeMD business performance
LFMD's ROA is up by 42% year-on-year and by 19% since the previous quarter
The ROS has grown by 33% YoY and by 25% from the previous quarter
Dividends
What is LFMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LFMD.
Financial health
How did LifeMD financials performed over time
LifeMD's total assets is 5% less than its total liabilities
LFMD's total liabilities is up by 45% year-on-year but it is down by 2.6% since the previous quarter
The quick ratio has contracted by 35% YoY and by 2.7% from the previous quarter
LFMD's debt to equity has dropped by 185% year-on-year and by 40% since the previous quarter
The debt is up by 33% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.